Clinical Trial Update: T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for advanced B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• EBV-specific cytotoxic T lymphocytes (EBV-CTL therapy)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED